Page last updated: 2024-11-13
epiduo
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
Adapalene, Benzoyl Peroxide Drug Combination: A pharmaceutical preparation of adapalene and benzoyl peroxide that is used as a DERMATOLOGIC AGENT for the topical treatment of ACNE. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 23653552 |
| SCHEMBL ID | 60989 |
| MeSH ID | M000603809 |
Synonyms (12)
| Synonym |
|---|
| benzoyl peroxide - differin mixt. |
| epiduo forte |
| adapalene / benzoyl peroxide |
| 1194805-81-6 |
| epiduo |
| adapalene-benzoyl peroxide mixt. |
| adapalene-bpo |
| adapalene, benzoyl peroxide drug combination |
| benzoyl peroxide / adapalene |
| SCHEMBL60989 |
| DTXSID30152465 |
| 6-[3-(1-adamantyl)-4-methoxyphenyl]naphthalene-2-carboxylic acid;benzoyl benzenecarboperoxoate |
Research Excerpts
Toxicity
| Excerpt | Reference | Relevance |
|---|---|---|
| "5% is efficacious and safe in patients with FST I-VI with moderate and severe inflammatory acne." | ( Adapalene/Benzoyl Peroxide Gel 0.3%/2.5%: A Safe and Effective Acne Therapy in All Skin Phototypes. Alexis, AF; Cook-Bolden, FE; York, JP, 2017) | 0.46 |
| "5 was safe and well-tolerated." | ( Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne. Barankin, B; Bissonnette, R; Chavda, R; Dréno, B; Gagné-Henley, A; Kerrouche, N; Lynde, C; Tan, J, 2019) | 0.51 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (16)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (87.50) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 66.90
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (66.90) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 10 (62.50%) | 5.53% |
| Reviews | 2 (12.50%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (25.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||